Skip to Content
Merck
All Photos(1)

Key Documents

F9263

Sigma-Aldrich

N-Fmoc-L-Asparagine (DOD)

Sign Into View Organizational & Contract Pricing


About This Item

Empirical Formula (Hill Notation):
C34H32N2O7
CAS Number:
Molecular Weight:
580.63
MDL number:
UNSPSC Code:
12352200
PubChem Substance ID:

functional group

Fmoc

storage temp.

−20°C

SMILES string

COc1ccc(cc1)C(NC(=O)C[C@H](NC(=O)OCC2c3ccccc3-c4ccccc24)C(O)=O)c5ccc(OC)cc5

InChI

1S/C34H32N2O7/c1-41-23-15-11-21(12-16-23)32(22-13-17-24(42-2)18-14-22)36-31(37)19-30(33(38)39)35-34(40)43-20-29-27-9-5-3-7-25(27)26-8-4-6-10-28(26)29/h3-18,29-30,32H,19-20H2,1-2H3,(H,35,40)(H,36,37)(H,38,39)/t30-/m0/s1

InChI key

NUINEVHFMAGARJ-PMERELPUSA-N

Application

Fmoc-L-aspartic acid is an N-terminally protected amino acid (Fmoc amino acid) used in solid-phase peptide synthesis (SPPS) to make peptides/glycopeptides containing an the aspartate residue.

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Rui Chen et al.
Methods in molecular biology (Clifton, N.J.), 751, 343-355 (2011-06-16)
This chapter describes a rapid and efficient approach for the solid-phase synthesis of N-linked glycopeptides that utilizes on-resin glycosylamine coupling to produce N-linked glycosylation sites. In this method, the full-length nonglycosylated peptide is first synthesized on a solid-phase support using
Trent Conroy et al.
Organic & biomolecular chemistry, 8(16), 3723-3733 (2010-06-23)
An efficient strategy for the preparation of N-linked glycopeptides is described. The method relies on the use of side chain protecting groups on aspartic acid residues, namely the allyl and Dmab esters, which are orthogonal to those utilised in Fmoc-strategy
M Mergler et al.
Journal of peptide science : an official publication of the European Peptide Society, 11(10), 650-657 (2005-04-26)
A newly developed Fmoc-Asp derivative, Fmoc-Asp beta-(2,3,4-trimethyl-pent-3-yl) ester, has been tried in the Fmoc-based SPPS of H-Val-Lys-Asp-Xaa-Tyr-Ile-OH, a well-established peptide model for studying base-catalysed aspartimide formation. When synthesizing the hexapeptide incorporating Gly, Arg(Pbf), Asn(Mtt), Asp(OtBu) or Cys(Acm) for Xaa, considerable
M Mergler et al.
Journal of peptide science : an official publication of the European Peptide Society, 9(1), 36-46 (2003-02-18)
A variety of Asp beta-carboxy protecting groups, Hmb backbone protection and a range of Fmoc cleavage protocols have been employed in syntheses of the model hexapeptide H-VKDGYI-OH to investigate the aspartimide problem in more detail. The extent of formation of
M Mergler et al.
Journal of peptide science : an official publication of the European Peptide Society, 9(8), 518-526 (2003-09-04)
The sequence dependence of base-catalysed aspartmide formation during Fmoc-based SPPS was systematically studied employing the peptide models H-Val-Lys-Asp-Xaa-Tyr-Ile-OH. The extent of formation of aspartimide and related by-products was determined by RP-HPLC. Considerable amounts of by-products were formed in the case

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service